Educational article

Macrolides

Macrolides bind the large bacterial ribosomal subunit. Members include erythromycin, clarithromycin and azithromycin. Spectrum and properties depend on the particular agent; activity against selected respiratory…

Overview

Macrolides bind the large bacterial ribosomal subunit. Members include erythromycin, clarithromycin and azithromycin. Spectrum and properties depend on the particular agent; activity against selected respiratory pathogens does not make the class universal.

Biology and practical meaning

Target methylation mediated by erm genes can confer MLSB cross-resistance to macrolides, lincosamides and streptogramin B. Other mechanisms, such as efflux, produce different profiles. Inducible resistance is assessed using an accepted organism-specific method.

Spectrum, exposure and AST

Spectrum describes the range of organisms an agent can act against; activity against a particular isolate is assessed separately. Access to the target, target changes, enzymes and efflux can alter activity. Agents in the same class are not completely interchangeable.

Pharmacokinetics describes distribution and elimination; pharmacodynamics links exposure to effect. Blood concentrations and exposure at the infection site can differ. A lower MIC number for a different antibiotic therefore does not establish superior clinical activity.

S, I and R are interpreted using a current standard for the organism–agent pair. Under EUCAST, I means susceptible with increased exposure. It does not mean resistant and does not independently specify a treatment regimen. Decisions also depend on the site, patient, contraindications, interactions and current guidance. This article explains mechanisms and terminology. The 2025 AWaRe classification concerns use policy, while the 2022 AWaRe book has subsequent updates; neither replaces an individual AST result.

Sources

Read next

Educational material from AMR Atlas. Does not replace clinical guidance or laboratory procedures.

Open interactive reader